Rationale, design, and baseline characteristics of the Study assessInG the mo...

xiyu

题名	Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure.
作者	Fox K1, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R.
杂志	Am Heart J.
年|卷|期	2013 Oct;166(4):
页码	654-661.e6.
链接	http://www.ncbi.nlm.nih.gov/pubmed/24093844

shixiwu

1

shixiwu

1